Guided by innovation, Beckman Coulter Diagnostics supports healthcare providers in delivering enhanced patient care through accurate diagnostic information.
Dedicated to improving healthcare outcomes for patients by leveraging the power of science and technology, the Beckman Coulter family is driven by passion to elevate the diagnostic laboratory's role in improving healthcare outcomes. Its diagnostic systems are integrated in hospitals, reference laboratories, in complex biomedical testing and physician offices all over the world.
Beckman Coulter has been an operating company of Danaher Corporation since 2011, with headquarters in Brea, Calif., and more than 11,000 global employees dedicated to making the world a healthier place.
During Medlab, we spoke with Nurgul Vatansever, Vice President EEMEA (Eastern Europe, , Middle East & Africa) at Beckman Coulter Diagnostics about the impact of the pandemic in the diagnostics industry.
Vice President Commercial Eastern Europe, Middle East & Africa of Beckman Coulter, Nurgul Vatansever
How does participating in Medlab encourage organisations to open dialogue on client needs?
As you know, Medlab is one of the most key events, gathering around 20,000 attendees from more than 60 countries. In the last two years, the pandemic paralysed the entire world as many regions observed a lockdown, limiting face to face interaction. This year Medlab marks the return to normal by providing a platform for us to reunite with our customers. Beckman Coulter is passionate about listening to our customers and understanding their needs. Having the opportunity to showcase our latest technology and solutions in person is ideal, as nothing replaces face to face interaction. We’ve missed that, and thanks to Medlab, we were all brought together again.
Can you tell us about how Beckman is supporting customers in your region, which is East Europe Middle East and Africa, during the pandemic?
The challenges born out of the pandemic were unforeseen, creating uncertainty. However, the crisis drove us to become more agile, adaptive and innovate further. This is a test for resilience, as the landscape created by the pandemic is unpredictable, but it also presents an opportunity to grow. Healthcare is becoming the top priority and many of our customers expect improved outcomes, efficiency, and increased access to solutions, and they are looking for partnerships which address their challenges.
Beckman Coulter is committed to our customers in supporting them through the toughest challenges, we strive to have positive impact as the partner of choice in developing sustainable health care for one patient at a time.